Date: 2016-07-11
Type of information: Nomination
Compound:
Company: Theradiag (France)
Therapeutic area: Autoimmune diseases – Inflammatory diseases - Rheumatic diseases - Digestive diseases - Diagnostic
Type agreement: nomination
Action mechanism:
Disease:
Details: * On July 11, 2016, Theradiag, a company specializing in in vitro diagnostics and theranostics, announced
Vincent Fert’s appointment to the Company’s Board of Directors. Vincent Fert is joining Theradiag’s Board of Directors, taking over the duties of Jean-Paul Prieels. Vincent was the Co-Founder and Chief Executive Officer of Ipsogen. He subsequently became Vice President, Program Lead Personalized Healthcare at Qiagen, and is currently Chairman and Chief Executive Officer of HalioDX, a company he co-founded that develops diagnostic tests measuring the immune response in oncology.
Financial terms:
Latest news:
